Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 16:00
Sinovac Biotech Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 327.45M |
| September 30, 2020 | 115.45M |
| June 30, 2020 | 52.33M |
| March 31, 2020 | 15.39M |
| December 31, 2019 | 81.11M |
| September 30, 2019 | 64.34M |
| June 30, 2019 | 64.04M |
| March 31, 2019 | 36.55M |
| December 31, 2018 | 53.21M |
| September 30, 2018 | 53.95M |
| June 30, 2018 | 75.15M |
| March 31, 2018 | 47.34M |
| December 31, 2016 | 31.36M |
| September 30, 2016 | 28.74M |
| June 30, 2016 | 1.377M |
| March 31, 2016 | 10.95M |
| December 31, 2015 | 22.95M |
| September 30, 2015 | 16.76M |
| June 30, 2015 | 18.49M |
| March 31, 2015 | 9.207M |
| December 31, 2014 | 20.15M |
| September 30, 2014 | 17.15M |
| June 30, 2014 | 12.09M |
| March 31, 2014 | 13.55M |
| December 31, 2013 | 22.20M |
| Date | Value |
|---|---|
| September 30, 2013 | 22.08M |
| June 30, 2013 | 17.45M |
| March 31, 2013 | 10.05M |
| December 31, 2012 | 19.59M |
| September 30, 2012 | 14.29M |
| June 30, 2012 | 9.365M |
| March 31, 2012 | 5.974M |
| December 31, 2011 | 21.14M |
| September 30, 2011 | 15.36M |
| June 30, 2011 | 15.66M |
| March 31, 2011 | 4.583M |
| December 31, 2010 | 9.142M |
| September 30, 2010 | 9.552M |
| June 30, 2010 | 10.26M |
| March 31, 2010 | 4.444M |
| December 31, 2009 | 36.39M |
| September 30, 2009 | 21.22M |
| June 30, 2009 | 20.02M |
| March 31, 2009 | 6.566M |
| December 31, 2008 | 12.36M |
| September 30, 2008 | 8.754M |
| June 30, 2008 | 16.52M |
| March 31, 2008 | 8.862M |
| December 31, 2007 | 9.202M |
| September 30, 2007 | 10.83M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
15.39M
Minimum
Mar 2020
327.45M
Maximum
Dec 2020
102.87M
Average
64.34M
Median
Sep 2019
Revenue (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | 6.874M |
| Zai Lab Ltd | 65.83M |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |